TGF-β1 Promotes in Vitro Development of Dendritic Cells from CD34+ Hemopoietic Progenitors

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1499-1507

  Strobl, Herbert ^a   Riedl, Elisabeth ^a   Scheinecker, Clemens ^a   Bello Fernandez, Concha ^a   Pickl, Winfried F ^b   Rappersberger, Klemens ^b   Majdic, Otto ^b   Knapp, Walter ^b,c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GRANULE; CULTURE MEDIUM; CYTOLOGY; DENDRITIC CELL; DRUG EFFECT; FETUS BLOOD; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MOUSE; NEWBORN; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYTOPLASMIC GRANULES; DENDRITIC CELLS; FETAL BLOOD; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INFANT, NEWBORN; MICE; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030586565     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Scheicher, C., M. Mehlig, R. Zecher, and K. Reske. 1992. Dendritic cells from mouse bone marrow: In vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 154: 253.
2. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
3. Inaba, K., R. M. Steinman, M. D. Witmer-Pack, H. Aya, M. Inaba, T. Sudo, S. Wolpe, and G. Schuler. 1992. Identification of proliferating dendritic cell precursors in mouse blood. Blood 175:1157.
4. Romani, N., S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinmann, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
5. Reid, C. D. L., P. R. Fryer, C. Clifford, A. Kirk, J. Tikerpae, and S. C. Knight. 1990. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human marrow and peripheral blood. Blood 76: 1139.
6. + progenitors in human bone marrow. J. Immunol. 149:2681.
7. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-a cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
8. Santiago-Schwarz, F., N. Divaris, C. Kay, and S. E. Carsons. 1993. Mechanisms of tumor Necrosis factor and granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 82:3019.
9. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109.
10. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J. Immunol. 154:5851.
11. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J. Exp. Med. 182:1111.
12. Mackensen, A., B. Herbst, G. Köhler, G. Wolff-Vorbeck, F. M. Rosenthal, H. Veelken, P. Kulmburg, H. E. Schaefer, R. Mertelsmann, and A. Lindemann. 1995. Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood 86:2699.
13. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer cells, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3:459.
14. + hematopoietic progenitor cells. Blood 87:1292.
15. Childs, C. B., J. A. Proper, R. F. Tucker, and H. L. Moses. 1982. Serum contains a platelet-derived transforming growth factor. Proc. Natl. Acad. Sci. USA 79: 5312.
16. Kashihara, M., M. Ueda, Y. Horiguchi, F. Furukawa, M. Hanaoka, and S. Imamura. 1986. A monoclonal antibody specifically reactive to human Langerhans cells. J. Invest. Dermatol. 87:602.
17. + hemopoietic progenitor cells. Blood 86:4115.
18. Tucker, R., G. Shiley, H. Moses, and R. Holley. 1984. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science 226:705.
19. Roberts, A., M. Anzano, L. Wakefield, N. Roche, D. Stern, and M. Sporn. 1985. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119.
20. Ottmann, O. G., and L. M. Pelus. 1988. Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells. J. Immunol. 140:2661.
21. Keller, J. R., S. E. W. Jacobsen, K. T. Sill, L. R. Ellingsworth, and F. W. Ruscetti. 1991. Stimulation of granulopoiesis by transforming growth factor β: synergy with granulocyte/macrophage-colony-stimulating factor. Proc. Natl. Acad. Sci. USA 88:7190.
22. Piabicello, W., D. Ferrero, F. Sanavio, R. Badoni, A. Stacchini, A. Severino, and M. Aglietta. 1991. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. Exp. Hematol. 19:1084.
23. Bursuker, I., K. M. Neddermann, B. A. Petty, B. Schacter, G. L. Spitalny, M. A. Tepper, and R. D. Pasternak. 1992. In vivo regulation of hemopoiesis by transforming growth factor beta 1: stimulation of GM-CSF- and M-CSF-dependent murine bone marrow precursors. Exp. Hematol. 20:431.
24. Celada, A., and R. A. Maki. 1992. Transforming growth factor-β enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages. J. Immunol. 148: 1102.
25. Krystal, G., V. Lam, W. Dragowska, C. Takahashi, J. Appel, A. Gontier, A. Jenkins, H. Lam, L. Quon, and P. Lansdorp. 1994. Transforming growth factor β1 is an inducer of erythroid differentiation. J. Exp. Med. 180:851.
26. Fujita, M., M. Kashihara-Sawami, Y. Horiguchi, F. Furukawa, M. Ueda, and S. Imamura. 1990. Langerhans cells in human allergic contact dermatitis contain varying numbers of Birbeck granules: double staining immunohistochemistry with OKT6 and Lag antibody. Histochemistry 94:497.
27. Fujita, M., F. Furukawa, Y. Horiguchi, U. Masamichi, M. Kashihira-Sawami, and S. Imamaura. 1991. Regional development of Langerhans cells and formation of Birbeck granules in human embrionic and fetal skin. J. Invest. Dermatol. 79:65.
28. Steinman, R. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
29. + hematopoietic precursor cells. Blood 87:535.
30. O'Connor-McCourt, M. D., and L. M. Wakefield. 1987. Latent transforming growth factor-β in serum. J. Biol. Chem. 262:14090.
31. Allen, J. B., H. L. Wong, P. M. Guyre, G. L. Simon, and S. M. Wahl. 1991. Association of circulating receptor FcγRIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-β. J. Clin. Invest. 87:1773.
32. Anscher, M. S., W. P. Peters, H. Reisenbichler, W. P. Petros, D. Pharm, and R. L. Jirtle. 1993. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N. Engl. J. Med. 328:1592.
33. Ivanovic, V., A. Melman, B. Davis-Joseph, M. Valcic, and J. Geliebter. 1995. Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nat. Med. 1:282.
34. Grainger, D. J., J. Wakefield, H. W. Bethell, R. W. Farndale, and J. C. Metcalfe. 1995. Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin. Nat. Med. 1:932.
35. Grainger, D. J. 1995. The serum concentration of active transforming growth factor β is severely depressed in advanced artherosclerosis. Nat. Med. 1:282.
36. Massagué, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6:597.
37. Massagué, J., L. Attisano, and J. L. Wrana. 1994. The TGF-β family and its composite receptors. Trends Cell Biol. 4:172.
38. Moore, M. A. S. 1991. Clinical implication of positive and negative hematopoietic stem cell regulators. Blood 78:1.
39. Cashman, J. D., A. C. Eaves, E. W. Raines, R. Ross, and C. J. Eaves. 1990. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96.
40. Keller, J. R., S. H. Bartelmez, E. Sitnicka, F. W. Ruscetti, M. Ortiz, J. M. Gooya, and S. E. W. Jacobsen. 1994. Distinct and overlapping direct effects of macrophage inflammatory protein-1a and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood 84:2175.
41. Hatzfeld, J., M. L. Li, E. L. Brown, H. Sookdea, J. P. Levesque, T. O'Toole, C. Gurney, S. C. Clark, and A. Hatzfeld. 1991. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonicleotides. J. Exp. Med. 174:925.
42. -++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp. Hematol. 21:1442.
43. + human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp. Hematol. 22:903.
44. Jacobsen, F. W., T. Stokke, and S. E. W. Jacobsen. 1995. Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86:2957.
45. Keller, J. R., C. Mantel, G. K. Sing, L. R. Ellingsworth, S. K. Ruscetti, and F. W. Ruscetti. 1988. Transforming growth factor β1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med. 168:737.
46. Lotem, J., and L. Sachs. 1990. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor β1 in normal and leukemic myeloid cells. Blood 76:1315.
47. Nestle, F. O., Zheng, X.-G., Thompson, C. B., Turka, L. A., and Nickoloff, B. J. 1993. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151: 6535.
48. Thomas, R., L. S. Davis, and P. E. Lipsky. 1993. Isolation and characterization of human peripheral blood dendritic cells. J. Immunol. 150:821.
49. Borkowski, T. A., J. Letterio, C. Mackall, A. Farr, D. Geiser, R. Gress, and M. C. Udey. 1995. The skin of TGF-β1 null mice is devoid of epidermal Langerhans cells (LC). J. Invest. Dermatol. 104:568 (Abstr.).
50. Myazono, K., and C.-H. Hjeldin. 1989. Role for carbohydrate structures in TGF-β1 latency. Nature 338:158.
51. Lyons, R. M., L. E. Gentry, A. F. Purchio, and H. L. Moses. 1990. Mechanisms of activation of latent recombinant transforming growth factor β by plasmin. J. Cell. Biol. 110:1361.
52. Nunes, I., R. L. Shapiro, and D. Rifkin. 1995. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155: 1450.
53. Grabbe, S., S. Beissert, T. Schwarz, and R. D. Granstein. 1995. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today 16:117.
54. Young, J. W., and K. Inaba. 1996. Dendritic cells as adjuvants for class I major histocompalibility complex-restricted antitumor immunity. J. Exp. Med. 183:7.